Arndt Hartmann

1.9k total citations
52 papers, 606 citations indexed

About

Arndt Hartmann is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Arndt Hartmann has authored 52 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Arndt Hartmann's work include Bladder and Urothelial Cancer Treatments (7 papers), Renal cell carcinoma treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Arndt Hartmann is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Renal cell carcinoma treatment (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Arndt Hartmann collaborates with scholars based in Germany, United States and Austria. Arndt Hartmann's co-authors include Abbas Agaimy, Tilman T. Rau, Robert Stoehr, Bruno Märkl, Melanie Straub, Gerald Niedobitek, Thomas Mentzel, Katja Specht, Anna‐Carinna Reis and Bastian Schilling and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Arndt Hartmann

46 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arndt Hartmann Germany	13	238	169	168	129	109	52	606
Sang Ho Kim South Korea	15	199 0.8×	110 0.7×	235 1.4×	109 0.8×	67 0.6×	33	673
Go Eun Bae South Korea	13	137 0.6×	155 0.9×	144 0.9×	102 0.8×	97 0.9×	44	529
Kaishi Satomi Japan	17	274 1.2×	302 1.8×	188 1.1×	161 1.2×	139 1.3×	76	978
Robin Wachowiak Germany	15	231 1.0×	135 0.8×	292 1.7×	166 1.3×	77 0.7×	41	731
King F. Kwong United States	16	191 0.8×	225 1.3×	112 0.7×	212 1.6×	74 0.7×	27	751
Navid Redjal United States	13	140 0.6×	94 0.6×	196 1.2×	139 1.1×	50 0.5×	35	656
Ido Didi Fabian Israel	20	194 0.8×	109 0.6×	171 1.0×	137 1.1×	73 0.7×	84	1.2k
Liangrui Zhou China	16	132 0.6×	96 0.6×	208 1.2×	106 0.8×	100 0.9×	30	546
Sarah L. McCarron Ireland	7	179 0.8×	80 0.5×	161 1.0×	94 0.7×	116 1.1×	11	526
Richard Cheney United States	14	232 1.0×	259 1.5×	307 1.8×	80 0.6×	83 0.8×	33	755

Countries citing papers authored by Arndt Hartmann

Since Specialization

Citations

This map shows the geographic impact of Arndt Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arndt Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arndt Hartmann more than expected).

Fields of papers citing papers by Arndt Hartmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arndt Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arndt Hartmann. The network helps show where Arndt Hartmann may publish in the future.

Co-authorship network of co-authors of Arndt Hartmann

This figure shows the co-authorship network connecting the top 25 collaborators of Arndt Hartmann. A scholar is included among the top collaborators of Arndt Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arndt Hartmann. Arndt Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trufa, Denis I., Mircea T. Chiriac, Carol Geppert, et al.. (2025). Dietary ω−3 polyunsaturated fatty acids (PUFAs) reduce cholesterol-driven non-small cell lung cancer (NSCLC) progression in mouse models of disease. Communications Medicine. 5(1). 432–432.

Sangoi, Ankur R., Ankit Tiwari, Mahmut Akgül, et al.. (2025). Perivascular epithelioid cell tumors of the urinary bladder: a multi-institutional clinicopathologic and molecular analysis of 21 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

Knöll, Antje, et al.. (2025). PD-L1-Expression in primary and recurrent vulvar squamous cell cancer. Gynecologic Oncology. 193. 98–104. 1 indexed citations

Griffin, Jon, Arndt Hartmann, & Éva Compérat. (2024). Variation in cystectomy pathology reporting practice—results from an international survey of 212 pathologists. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 485(5). 879–888.

Eckstein, Markus, Rudolf Jung, Verena Lieb, et al.. (2024). Prognostic and Predictive Potential of CCL5 Expression in Muscle-Invasive Bladder Cancer Patients. International Journal of Molecular Sciences. 25(12). 6325–6325. 3 indexed citations

Geppert, Carol I., Simone Bertz, Robert Stöhr, et al.. (2024). Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 769–779.

Singh, Jeeshan, Arndt Hartmann, Katja Evert, et al.. (2023). Anti-DNA-IgM Favors the Detection of NET-Associated Extracellular DNA. International Journal of Molecular Sciences. 24(4). 4101–4101. 2 indexed citations

Strissel, Pamela L., Reiner Strick, Carol‐Immanuel Geppert, et al.. (2023). Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.. Journal of Clinical Oncology. 41(6_suppl). 554–554. 1 indexed citations

Fasching, Peter A., Alexander Hein, Hans‐Christian Kolberg, et al.. (2023). Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041). European Journal of Cancer. 184. 1–9. 25 indexed citations

10.

Erlmeier, Franziska, Stefanie Zschäbitz, Marie Mikuteit, et al.. (2023). The role of claudin-6 in chromophobe renal cell carcinoma.. PubMed. 38(4). 403–407. 2 indexed citations

11.

Berney, Daniel M., Ian A. Cree, Holger Moch, et al.. (2022). An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 81(4). 459–466. 44 indexed citations

12.

Hartmann, Arndt, et al.. (2022). Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19. Frontiers in Immunology. 13. 835156–835156. 29 indexed citations

13.

Singh, Jeeshan, Irmgard Herrmann, Aparna Mahajan, et al.. (2022). A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19. International Journal of Molecular Sciences. 23(23). 15126–15126. 2 indexed citations

14.

Voskens, Caroline, Francesco Vitali, Sebastian Zundler, et al.. (2022). Autologous regulatory T-cell transfer in refractory ulcerative colitis with concomitant primary sclerosing cholangitis. Gut. 72(1). 49–53. 54 indexed citations

15.

Kapsner, Lorenz A., Agnes Hotz‐Wagenblatt, И. Н. Лебедев, et al.. (2021). BiasCorrector: Fast and accurate correction of all types of experimental biases in quantitative DNA methylation data derived by different technologies. International Journal of Cancer. 149(5). 1150–1165. 1 indexed citations

16.

Kranz, Georg S., Gregory M. James, Thomas Vanicek, et al.. (2019). Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET. Molecular Psychiatry. 26(3). 1009–1018. 27 indexed citations

17.

Musa, Gentian, Machteld J. van Amerongen, Marc P. Stemmler, et al.. (2019). Gpr126 (Adgrg6) is expressed in cell types known to be exposed to mechanical stimuli. Annals of the New York Academy of Sciences. 1456(1). 96–108. 19 indexed citations

18.

Naschberger, Elisabeth, Melanie Langheinrich, Felix B. Engel, et al.. (2018). Isolation of Human Endothelial Cells from Normal Colon and Colorectal Carcinoma - An Improved Protocol. Journal of Visualized Experiments. 5 indexed citations

19.

Moskalev, Evgeny A., Robert Stöhr, Ralf J. Rieker, et al.. (2013). Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 462(4). 409–419. 29 indexed citations

20.

Lermann, Johannes, Grit Mehlhorn, Stefan P. Renner, et al.. (2011). Is Laparoscopic Extirpation of the Cervical Stump After Laparoscopic Supracervical Hysterectomy Justified in Women with Incidentally Found Atypical Endometrial Hyperplasia?. Journal of Laparoendoscopic & Advanced Surgical Techniques. 21(8). 705–709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact